Stefan Uderhardt

Stefan Uderhardt

Auto-generated profile, based on publicly available information

Stefan Uderhardt

Affiliations Department of Medicine 3 - Rheumatology and Immunology, FAU and Universitätsklinikum Erlangen, Erlangen, Germany, Deutsches Zentrum für Immuntherapie, FAU, Erlangen, Germany, Exploratory Research Unit, Optical Imaging Competence Center Erlangen, FAU, Erlangen, Germany

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Cell
Verified
Journal Article
Closed access
SUStefan Uderhardt
Stefan Uderhardt
AMAndrew J. Martins
Andrew J. Martins
JTJohn S. Tsang
John S. Tsang
TLTim Lämmermann
Tim Lämmermann
RGRonald N. Germain
Ronald N. Germain

7 November 2016 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
RPRené Pfeifle
René Pfeifle
TRTobias Rothe
Tobias Rothe
Natacha IpseizNatacha Ipseiz
Natacha Ipseiz
HSHans U Scherer
Hans U Scherer
SCStephan Culemann
Stephan Culemann
GKGerhard Krönke
Gerhard Krönke

1 May 2012 in Immunity
Verified
Journal Article
Closed access
SUStefan Uderhardt
Stefan Uderhardt
Martin HerrmannMartin Herrmann
Martin Herrmann
OOOlga V. Oskolkova
Olga V. Oskolkova
SASusanne Aschermann
Susanne Aschermann
WBWolfgang Bicker
Wolfgang Bicker
GKGerhard Krönke
Gerhard Krönke

17 January 2020 in Science
Verified
Journal Article
Closed access
PDF file
SFSpencer A. Freeman
Spencer A. Freeman
SUStefan Uderhardt
Stefan Uderhardt
ASAmra Saric
Amra Saric
RCRichard F. Collins
Richard F. Collins
CBCatherine M. Buckley
Catherine M. Buckley
SGSergio Grinstein
Sergio Grinstein
Ion fluxes resolve organellar volume: Animal cells continuously sample the surrounding medium, a feature accentuated in immune cells. Sampling is accomplished by trapping external medium into membrane-bound vesicles or vacuoles. These structures are promptly resolved, thus avoiding accumulation of endomembranes and volume expansion. In a variety of cultured cells, Freeman et al. found that this resolution entails conversion of spherical vacuoles into thin tubules, a process that involves marked changes in surface-to-volume ratio (see the Perspective by King and Smythe). Shrinkage of membrane-bound structures is driven by ion fluxes and subsequent osmotic transfer of water. Shriveled vacuoles attract curvature-sensing proteins that promote the extension of fine tubules. Ion channels thereby control membrane remodeling, enabling receptor recycling and proper routing of cellular cargo. Science , this issue p. 301 ; see also p. 246

31 May 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SUStefan Uderhardt
Stefan Uderhardt
JAJochen A. Ackermann
Jochen A. Ackermann
TFTobias Fillep
Tobias Fillep
VHVictoria J. Hammond
Victoria J. Hammond
JWJohann Willeit
Johann Willeit
GKGerhard Krönke
Gerhard Krönke
Blood coagulation is essential for physiological hemostasis but simultaneously contributes to thrombotic disease. However, molecular and cellular events controlling initiation and propagation of coagulation are still incompletely understood. In this study, we demonstrate an unexpected role of eosinophils during plasmatic coagulation, hemostasis, and thrombosis. Using a large-scale epidemiological approach, we identified eosinophil cationic protein as an independent and predictive risk factor for thrombotic events in humans. Concurrent experiments showed that eosinophils contributed to intravascular thrombosis by exhibiting a strong endogenous thrombin-generation capacity that relied on the enzymatic generation and active provision of a procoagulant phospholipid surface enriched in 12/15-lipoxygenase–derived hydroxyeicosatetraenoic acid–phosphatidylethanolamines. Our findings reveal a previously unrecognized role of eosinophils and enzymatic lipid oxidation as regulatory elements that facilitate both hemostasis and thrombosis in response to vascular injury, thus identifying promising new targets for the treatment of thrombotic disease.

28 March 2023 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SCStephan Culemann
Stephan Culemann
KKKatharina Knab
Katharina Knab
MEMaximilien Euler
Maximilien Euler
AWAnja Wegner
Anja Wegner
HGHilal Garibagaoglu
Hilal Garibagaoglu
GKGerhard Krönke
Gerhard Krönke
Clodronate liposomes (Clo-Lip) have been widely used to deplete mononuclear phagocytes (MoPh) to study the function of these cells in vivo. Here, we revisited the effects of Clo-Lip together with genetic models of MoPh deficiency, revealing that Clo-Lip exert their anti-inflammatory effects independent of MoPh. Notably, not only MoPh but also polymorphonuclear neutrophils (PMN) ingested Clo-Lip in vivo, which resulted in their functional arrest. Adoptive transfer of PMN, but not of MoPh, reversed the anti-inflammatory effects of Clo-Lip treatment, indicating that stunning of PMN rather than depletion of MoPh accounts for the anti-inflammatory effects of Clo-Lip in vivo. Our data highlight the need for a critical revision of the current literature on the role of MoPh in inflammation.